A study published in BMJ Medicine in late April adds to a growing pile of evidence that for endurance athletes the cleanest longevity gains come from doing more than one thing. The pooled analysis, drawing on two large prospective cohorts, found that participants who walked the most had a 17 per cent lower all-cause mortality risk compared with those who walked the least, while regular running and resistance training were each associated with around a 13 per cent reduction. The headline finding for runners, however, sits underneath those numbers: variety in activity type appears to lower mortality risk independently of total weekly volume.
The authors’ working argument is that the marginal returns of adding a third or fourth activity beat the marginal returns of simply running more once an athlete is already running regularly. People who reported a mix of running, walking, cycling and resistance work consistently outperformed otherwise similar single-activity exercisers on the cohort’s ten-year mortality outcomes, even when total active minutes were comparable. That pattern held after adjustment for age, body mass index, smoking status, occupation and self-reported diet quality.
For runners, the practical reading is fairly mundane: brisk daily walking on rest or recovery days, and a couple of short resistance sessions through the training week, are doing more longevity work than another easy mileage hour. That dovetails with recent meta-analyses on strength training and injury prevention in runners, and with the post-marathon brain-myelin recovery work published in Nature Metabolism, both of which point in the direction of cross-modal stress as a feature rather than a bug of healthy ageing.
The BMJ Medicine paper has limitations that should temper any single-paper enthusiasm. Activity types were self-reported and re-classified into broad categories, and the cohort skewed older, white and middle-class, as is true of most large UK and European exercise cohorts. The authors are explicit that the findings should be read as hypothesis-generating for the more athletic end of the distribution, where almost everyone in the sample is already meeting weekly aerobic guidelines and the question is what additional patterns matter on top of that.
What the study does usefully reinforce is the case against the single-modality identity that elite distance running culture sometimes promotes. The more interesting longevity question for a serious runner is no longer whether to lift or walk in addition to running; it is how much of each, in what sequence, and at what intensity. That is harder to answer from one cohort study, but it is the question the next wave of the running-and-longevity research programme is now visibly converging on.